The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TAXYNERGY: Randomized trial of early switch from first-line docetaxel (D) to cabazitaxel (C) or vice versa with circulating tumor cell (CTC) biomarkers in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
 
Scott T. Tagawa
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Genentech; Janssen; Medivation; Sanofi
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech (Inst); Janssen (Inst); Lilly (Inst); Millennium (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst)
 
Emmanuel S. Antonarakis
Honoraria - Astellas Pharma; Dendreon; ESSA; Janssen Biotech; Medivation; Sanofi
Consulting or Advisory Role - Astellas Pharma; Dendreon; ESSA; Janssen Biotech; Medivation; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Novartis; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bavarian Nordic; Janssen Oncology; Millennium; Novartis; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Marie Vanhuyse
Consulting or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Johnson & Johnson; Pfizer; Sanofi
Research Funding - sanofi (Inst)
 
Guru Sonpavde
Consulting or Advisory Role - Agensys; Argos Therapeutics; Bayer; Genentech; Merck; Novartis; Pfizer; Sanofi
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Onyx (Inst)
 
Scott A. North
Honoraria - Astellas Pharma; Janssen-Ortho; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology; Novartis; Pfizer; Sanofi
 
Costantine Albany
No Relationships to Disclose
 
Che-Kai Tsao
No Relationships to Disclose
 
John Stewart
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Atef Zaher
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Ted P. Szatrowski
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
Consulting or Advisory Role - EMD Serono (I); GlaxoSmithKline (I); Insys Therapeutics (I); Janssen (I)
Research Funding - Johnson & Johnson (I)
 
Wei Zhou
Employment - Sanofi
 
Giuseppe Galletti
No Relationships to Disclose
 
Daniel Worroll
No Relationships to Disclose
 
Mario A. Eisenberger
Honoraria - Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen; Sanofi
Research Funding - Genentech; Sanofi; Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Sanofi
 
David M. Nanus
No Relationships to Disclose
 
Paraskevi Giannakakou
Employment - Novartis (I)
Stock and Other Ownership Interests - Merck (I); Novartis (I)
Consulting or Advisory Role - Eisai
Research Funding - Eisai; Sanofi
Patents, Royalties, Other Intellectual Property - NIH/NCI (Inst)
Travel, Accommodations, Expenses - Eisai; Sanofi